Health News

The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

Read more

Filed under: Pharmacy News
Tags: Drug, Hepatitis, Pharmacy

Related posts

• Vertex submits NDA for telaprevir for treating hepatitis C (0)
  Vertex Pharmaceuticals Incorporated announced today that it has completed the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for telaprevir, Vertex's investigational treatment for people with hepatitis C. Read more [tags] Pharmacy News [/tags]
  
  
• Vertex receives FDA approval for INCIVEK to treat hepatitis C (0)
  Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved INCIVEK™ (telaprevir) tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease (some level of damage to the liver but the liver still functions), including cirrhosis (scarring of the liver). Read more [tags] Pharmacy News [...]
  
  
• Two new hepatitis C drugs effectively improve cure rates of African Americans (0)
  Two new drugs just approved by the Food and Drug Administration to treat hepatitis C genotype 1 significantly improved the cure rates of patients. One of the drugs was extremely effective in treating African Americans. Read more [tags] Pharmacy News [/tags]
  
  
• Treatment for HBV infection with entecavir followed by lamivudine results in virologic rebound (0)
  A two-year trial of entecavir followed by lamivudine (LAM) in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24% and 12% drug-resistance rate. Patients who continued on entecavir therapy throughout the study period had undetectable HBV DNA at the two-year endpoint. Details of this trial are published in [...]
  
  
• Three-drug cocktail more effective against hepatitis C virus (0)
  A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital. Read more [tags] Pharmacy News [/tags]